Detalhe da pesquisa
1.
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study.
Dermatol Ther
; 35(1): e15166, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676662
2.
Ixekizumab improves disease severity, clinical symptoms and quality of life in patients with genital psoriasis: A 24-week real-life experience.
Dermatol Ther
; 34(4): e14993, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34029442
3.
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study.
BMC Health Serv Res
; 21(1): 924, 2021 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488749
4.
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity.
J Am Acad Dermatol
; 69(6): 947-53, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24094540
5.
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis.
J Dermatolog Treat
; 31(7): 692-697, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963798
6.
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis.
PLoS One
; 15(8): e0237267, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785291
7.
Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.
Eur J Dermatol
; 21(5): 784-5, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21697068